Cell viability was assessed in both human (SJ-GBM2 mIDH1) and murine glioma (mIDH1 NPAI, mIDH1 CPAI, and mIDH1 RPAI) cells treated with ATG9b siRNAs, both in the presence and absence of IR. Here, ATG9B is linked to glioma.